We serve Chemical Name:5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole CAS:1238854-13-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole
CAS.NO:1238854-13-1
Synonyms:5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole
Molecular Formula:C10H8Br2N2
Molecular Weight:315.99200
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:28.68000
Exact Mass:313.90500
LogP:3.73410
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole Use and application,5-(bromomethyl)-3-(4-bromophenyl)-1H-pyrazole technical grade,usp/ep/jp grade.
Related News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. Cyclopentanecarboxylic acid, 4-amino-2,3-dihydroxy-, ethyl ester, manufacturers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. 2-dimethylaminoethanol hydrogen l-(+)-tartrate suppliers The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. 1-Chlorodocosane vendor & factory Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other. ,Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other.
